MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,126 | +151.2% | 16,440 | +108.4% | 0.18% | +150.7% |
| Q2 2023 | $285,066 | +3.1% | 7,890 | +6.0% | 0.07% | +6.0% |
| Q1 2023 | $276,619 | +49.3% | 7,440 | +81.9% | 0.07% | +48.9% |
| Q4 2022 | $185,318 | -71.8% | 4,090 | -56.5% | 0.04% | -71.2% |
| Q3 2022 | $656,000 | -14.0% | 9,400 | -17.3% | 0.16% | -13.3% |
| Q2 2022 | $763,000 | +121.2% | 11,360 | +170.5% | 0.18% | +45.2% |
| Q1 2022 | $345,000 | -44.0% | 4,200 | 0.0% | 0.12% | -5.3% |
| Q4 2021 | $616,000 | -5.8% | 4,200 | +13.5% | 0.13% | -33.2% |
| Q3 2021 | $654,000 | +990.0% | 3,700 | +900.0% | 0.20% | +1052.9% |
| Q2 2021 | $60,000 | -89.5% | 370 | -88.9% | 0.02% | -91.2% |
| Q1 2021 | $572,000 | -22.1% | 3,340 | 0.0% | 0.19% | -17.8% |
| Q4 2020 | $734,000 | +36.9% | 3,340 | +3.4% | 0.24% | +44.8% |
| Q3 2020 | $536,000 | +21.3% | 3,230 | -43.8% | 0.16% | +1.2% |
| Q1 2020 | $442,000 | +59.6% | 5,750 | +167.4% | 0.16% | +46.4% |
| Q4 2019 | $277,000 | – | 2,150 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |